A
Adam S. Helms
Researcher at University of Michigan
Publications - 59
Citations - 1869
Adam S. Helms is an academic researcher from University of Michigan. The author has contributed to research in topics: Hypertrophic cardiomyopathy & Cardiomyopathy. The author has an hindex of 19, co-authored 45 publications receiving 1197 citations. Previous affiliations of Adam S. Helms include University of Virginia & University of Virginia Health System.
Papers
More filters
Journal ArticleDOI
Genotype and lifetime burden of disease in hypertrophic cardiomyopathy insights from the sarcomeric human cardiomyopathy registry (SHaRe)
Carolyn Y. Ho,Sharlene M. Day,Euan A. Ashley,Michelle Michels,Alexandre C. Pereira,Daniel Jacoby,Allison L. Cirino,Jonathan C. Fox,Neal K. Lakdawala,James S. Ware,Colleen Caleshu,Adam S. Helms,Steven D. Colan,Francesca Girolami,Franco Cecchi,Christine E. Seidman,Christine E. Seidman,Gautam Sajeev,James Signorovitch,Eric M. Green,Iacopo Olivotto +20 more
TL;DR: The cumulative burden of HCM is substantial and dominated by heart failure and atrial fibrillation occurring many years after diagnosis, highlighting the need for close surveillance throughout life and the need to develop disease-modifying therapies.
Journal ArticleDOI
Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.
Eric D. Smith,Neal K. Lakdawala,Nikolaos Papoutsidakis,Gregory Aubert,Andrea Mazzanti,Anthony C. McCanta,Prachi P. Agarwal,Patricia Arscott,Lisa Dellefave-Castillo,Esther E. Vorovich,Kavitha Nutakki,Lisa D. Wilsbacher,Silvia G. Priori,Daniel Jacoby,Elizabeth M. McNally,Adam S. Helms +15 more
TL;DR: DSP cardiomyopathy is a distinct form of arrhythmogenic cardiopathy characterized by episodic myocardial injury, left ventricular fibrosis that precedes systolic dysfunction, and a high incidence of ventricular arrhythias.
Journal ArticleDOI
Catheter Ablation of Atrial Fibrillation Without Fluoroscopy Using Intracardiac Echocardiography and Electroanatomic Mapping
John D. Ferguson,Adam S. Helms,J. Michael Mangrum,Srijoy Mahapatra,Pamela K. Mason,Kenneth C Bilchick,George McDaniel,David Wiggins,John P. DiMarco +8 more
TL;DR: Catheter ablation of atrial fibrillation without fluoroscopy is feasible and merits further attention, and may be especially helpful in preventing x-ray exposure in children, pregnant women, and obese patients undergoing left atrial ablation.
Journal ArticleDOI
Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial
Sara Saberi,Matthew T. Wheeler,Jennifer L. Bragg-Gresham,Whitney E. Hornsby,Prachi P. Agarwal,Anil K. Attili,Maryann Concannon,Annika M. Dries,Yael Shmargad,Heidi Salisbury,Suwen Kumar,Jonathan J. Herrera,Jonathan Myers,Adam S. Helms,Euan A. Ashley,Sharlene M. Day +15 more
TL;DR: In this preliminary study involving patients with hypertrophic cardiomyopathy, moderate-intensity exercise compared with usual activity resulted in a statistically significant but small increase in exercise capacity at 16 weeks, as well as the long-term safety of exercise at moderate and higher levels of intensity.
Journal ArticleDOI
Relation of Left Atrial Volume from Three-Dimensional Computed Tomography to Atrial Fibrillation Recurrence Following Ablation
Adam S. Helms,J. Jason West,Amit R. Patel,Michael J. Lipinski,J. Michael Mangrum,J. Paul Mounsey,John P. DiMarco,John D. Ferguson +7 more
TL;DR: LA volume varies greatly in those with and without successful AF ablations, mean LA volume is significantly larger in thoseWith recurrence, and patients with LA volumes >135 ml are very likely to develop recurrent AF.